Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
Hyliion Holdings
HYLN
$663M
| $1.41M | ﹤0.01% |
799,672
+203,451
| +34% | +$409K |
|
|
MBX
2777
MBX Biosciences
MBX
$2.95B
| $1.4M | ﹤0.01% |
+46,753
| New | +$1.59M |
|
2778
Optical Cable Corp
OCC
$127M
| $1.39M | ﹤0.01% |
168,211
-100,721
| -37% | -$602K |
|
2779
ARS Pharmaceuticals
SPRY
$590M
| $1.38M | ﹤0.01% |
172,339
-3,783
| -2% | -$36.3K |
|
2780
CareCloud
CCLD
$94.3M
| $1.38M | ﹤0.01% |
377,567
+125,435
| +50% | +$358K |
|
|
API
2781
Agora
API
$326M
| $1.38M | ﹤0.01% |
389,029
+33,502
| +9% | +$142K |
|
|
AAUC
2782
Allied Gold Corp
AAUC
$2.64B
| $1.38M | ﹤0.01% |
44,305
-35,438
| -44% | -$1.07M |
|
2783
Bausch + Lomb
BLCO
$5.77B
| $1.36M | ﹤0.01% |
85,779
+9,971
| +13% | +$170K |
|
2784
The Joint Corp
JYNT
$119M
| $1.36M | ﹤0.01% |
153,754
+41,842
| +37% | +$381K |
|
2785
First National Corp
FXNC
$269M
| $1.35M | ﹤0.01% |
50,267
+20,466
| +69% | +$542K |
|
2786
Janux Therapeutics
JANX
$935M
| $1.34M | ﹤0.01% |
96,630
-127,664
| -57% | -$1.75M |
|
2787
LENSAR
LNSR
$68.8M
| $1.34M | ﹤0.01% |
224,934
| – | – |
|
2788
Citizens
CIA
$245M
| $1.34M | ﹤0.01% |
266,366
-4,910
| -2% | -$26.1K |
|
2789
Affinity Bancshares
AFBI
$140M
| $1.34M | ﹤0.01% |
60,098
| – | – |
|
2790
Santander
BSBR
$39.7B
| $1.32M | ﹤0.01% |
221,909
+67,224
| +43% | +$428K |
|
2791
Bridgford Foods
BRID
$58.4M
| $1.3M | ﹤0.01% |
174,714
-4
| -0% | -$31 |
|
2792
Sight Sciences
SGHT
$267M
| $1.29M | ﹤0.01% |
341,681
+40,346
| +13% | +$218K |
|
|
FVR
2793
FrontView REIT
FVR
$494M
| $1.28M | ﹤0.01% |
83,002
+63,840
| +333% | +$1.03M |
|
2794
Corbus Pharmaceuticals
CRBP
$170M
| $1.28M | ﹤0.01% |
136,602
+59,248
| +77% | +$499K |
|
2795
Akebia Therapeutics
AKBA
$327M
| $1.28M | ﹤0.01% |
921,923
-649,089
| -41% | -$892K |
|
2796
Caribou Biosciences
CRBU
$156M
| $1.28M | ﹤0.01% |
673,200
-332,810
| -33% | -$571K |
|
2797
Nautilus Biotechnolgy
NAUT
$215M
| $1.27M | ﹤0.01% |
329,123
+43,684
| +15% | +$107K |
|
|
DFMC
2798
U.S. Micro Cap Portfolio ETF
DFMC
$167M
| $1.27M | ﹤0.01% |
+25,000
| New | +$1.26M |
|
2799
Rapid7
RPD
$634M
| $1.26M | ﹤0.01% |
228,498
-55,904
| -20% | -$514K |
|
2800
Grab
GRAB
$13.5B
| $1.25M | ﹤0.01% |
341,881
+36,363
| +12% | +$154K |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.